Cellular Intelligence Welcomes Le Cun and Aims for Phase 2 for Parkinson's

Cellular Intelligence announces an agreement with Novo Nordisk to acquire STEM-PD, a cell therapy program for Parkinson's disease that is already ready for phase 2. The startup is focusing on a predictive model of cellular signals and welcomes Yann Le Cun to its scientific advisory board, alongside figures from the biotech industry.

A Parkinson's Program Ready for Phase 2 with Novo Nordisk

In May, Cellular Intelligence announced the conclusion of an agreement with Novo Nordisk regarding the acquisition of STEM-PD. This allogeneic cell treatment, aimed at Parkinson's disease, is already positioned to begin phase 2 clinical trials. Through this operation, the startup benefits from a product at an advanced clinical stage, providing it with the opportunity to validate the effectiveness of its artificial intelligence technologies in a therapeutic setting.

A Cellular Signaling Model with Predictive Ambitions

Cellular Intelligence is developing the Universal Virtual Cell-Signaling Model, an artificial intelligence specialized in cells. According to the startup, this model can predict how a cell, in any state, changes in response to external signals. Cellular Intelligence describes the traditional trial-and-error approach as slow and empirical, seeking to complement it with mechanistic predictions. This shift comes as many artificial intelligence laboratories focus on large language models.

Le Cun Joins the Scientific Advisory Board and Details His Approach

Yann Le Cun joins the scientific advisory board of Cellular Intelligence, alongside Bob Langer, Jens Nielsen, and Fabian Theis. He explains his interest in models that learn from data how the world works and predict the consequences of our actions, with living cells representing a particularly rich challenge. After leaving Meta, he founded Advanced Machine Intelligence Labs, where he serves as executive chairman, to develop world models intended for physical artificial intelligence. His interest in forms of AI beyond large language models motivated the creation of his startup and his participation in the scientific governance of Cellular Intelligence.